|
Tumor morphology
|
Ulcerative type
|
12 (12)
|
87.5 ± 11.7 %
|
0.251
|
87.5 ± 11.7 %
|
0.244
|
|
Diffuse type
|
18 (18)
|
68.0 ± 12.0 %
|
66.7 ± 12.4 %
|
|
Massive type
|
71 (70)
|
86.9 ± 4.7 %
|
88.1 ± 4.6 %
|
|
Depth of invasion
|
Mucosa/submucosa
|
0
|
–
|
0.022
|
–
|
0.029
|
|
Muscularis propria/subserosa
|
40 (40)
|
95.8 ± 4.1 %
|
94.7 ± 5.1 %
|
|
Beyond serosa (visceral peritoneum) without invasion of adjacent structures
|
43 (42)
|
71.3 ± 8.1 %
|
73.7 ± 8.0 %
|
|
Involvement of adjacent structures or organs
|
18 (18)
|
81.1 ± 9.9 %
|
80.4 ± 10.2 %
|
|
Involvement of regional lymph nodes
|
Negative
|
48 (48)
|
90.8 ± 5.1 %
|
0.038
|
89.4 ± 6.0 %
|
0.048
|
|
Positive
|
53 (52)
|
75.8 ± 6.7 %
|
77.8 ± 6.5 %
|
|
Invasion to adjacent structures or organs
|
No
|
79 (78)
|
87.8 ± 4.4 %
|
0.024
|
86.5 ± 4.8 %
|
0.028
|
|
Yes
|
22 (22)
|
69.4 ± 10.5 %
|
73.6 ± 10.2 %
|
|
High level of Ki-67
|
Negative
|
76 (75)
|
90.1 ± 3.8 %
|
<0.001
|
91.3 ± 3.8 %
|
<0.001
|
|
Positive
|
25 (25)
|
52.6 ± 14.4 %
|
48.0 ± 14.5 %
|
|
Bcl-2 expression
|
Negative
|
53 (52)
|
97.8 ± 2.2 %
|
<0.001
|
97.6 ± 2.4 %
|
<0.001
|
|
Positive
|
48 (48)
|
65.8 ± 8.2 %
|
65.8 ± 8.7 %
|
